HomeTVGN • NASDAQ
Tevogen Bio Holdings Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.36M | 366.00% |
Net income | -9.44M | -160.02% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.32M | -374.39% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.28M | 21.91% |
Total assets | 3.46M | -37.12% |
Total liabilities | 10.14M | -89.86% |
Total equity | -6.67M | — |
Shares outstanding | 183.89M | — |
Price to book | -11.44 | — |
Return on assets | -603.99% | — |
Return on capital | 667.46% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -9.44M | -160.02% |
Cash from operations | -3.05M | -54.20% |
Cash from investing | — | — |
Cash from financing | 2.00M | 373.65% |
Net change in cash | -1.05M | 32.59% |
Free cash flow | 190.70K | 118.97% |
Previous close
$1.03
Day range
$0.98 - $1.03
Year range
$0.26 - $3.09
Market cap
185.71M USD
Avg Volume
488.69K
P/E ratio
2.76
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2020
Headquarters
Website
Employees
18
